Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Pharmaceuticals

Sanofi Unveils Drug To Fight Malaria

March 12, 2007 | A version of this story appeared in Volume 85, Issue 11

Sanofi-Aventis says the first low-cost combination drug to combat malaria will soon be available throughout sub-Saharan Africa. The French drugmaker is working with a medical charity, Drugs for Neglected Diseases Initiative, to sell and distribute the new medicine, ASAQ, at a "no profit-no loss" price. ASAQ combines two of the most effective drugs known to treat malaria, artesunate (AS) and amodiaquine (AQ), and has been endorsed by the World Health Organization. To maximize access, Sanofi won't patent the medicine. This decision allows generic drug companies to manufacture their own inexpensive versions.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.